Diabetes Clinical Trials in San Francisco

Showing 1-20 of 405 trials

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321

INHALE-1st is a Phase 2, single-arm, multi-center, clinical study evaluating the safety and efficacy of Afrezza in combination with subcutaneously-injected basal insulin (BI) for youth 10 to \<18 years old with newly diagnosed stage 3 type 1 diabetes (T1D). The study will also evaluate the effect of an Afrezza plus BI reigmen on participant and parent/legally authorized representative satisfaction. Participants will be followed for 13 weeks during the main phase followed by an optional Extension Phase for participants continuing to use Afrezza in combination with BI for up to 26 weeks.

Type 1 Diabetes Mellitus

Mannkind Corporation100 participantsStarted Feb 2026

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +7 more locations

RECRUITINGPhase 3< 1 mile

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

NCT04786262

This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.

Diabetes Mellitus, Type 1Impaired Hypoglycemic AwarenessSevere Hypoglycemia

Vertex Pharmaceuticals Incorporated52 participantsStarted Mar 2021

Duarte, California, United States • San Francisco, California, United States • Miami, Florida, United States +26 more locations

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Diabetes Trials in Other Cities

Type 1 Diabetes Extension Study

Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes

Teplizumab in Pediatric Stage 2 Type 1 Diabetes

The Acute Effects of Specialty Coffee on Cognitive Function in People With Type 2 Diabetes

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

Food Insecurity Reduction & Strategy Team

Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D)

A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

Siplizumab in T1DM

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

Other Conditions in San Francisco